Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for a Phase I cabozantinib study involving people with HIV and advanced solid tumors, including its eligibility criteria, treatment arms, outcomes, locations, and posted study documents.SummaryDifference86%

- Check17 days agoChange DetectedAn NIH-wide notice about terminology during the agency transition appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the usual study content. This indicates the record is unavailable and users are shown a link to the homepage.SummaryDifference22%

- Check52 days agoChange DetectedThe page's Revision tag updated from v3.6.6 to v3.7.0, indicating an update to the page template/version used for this study record.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.